Wockhardt announced that National Institute of Allergy and Infectious Diseases NIAID part of the National Institutes of Health NIH United States of America USA is supporting a Phase 1 clinical trial of Wockhardts novel once-a-day multidrug-resistant MDR Gram-negative targeted antibiotic WCK 6777 The trial will be conducted at NIAIDs Phase I clinical trial units in the USA NIAID will sponsor the investigational new drug IND […]
Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 25 mg 5 mg 10 mg and 20 mg from the United States Food and Drug Administration USFDA to market a generic version of Bystolic nebivolol Tablets 25 mg 5 mg 10 mg and 20 mg of Allergan Sales LLC Nebivolol Tablets are indicated for the treatment of hypertension The product will be commercialized from […]
Lactose India will hold a meeting of the Board of Directors of the Company on 19 March 2022
NLC India announced that a power purchase agreement was signed between TANGEDCO and the company for procuring 1500 MW power from thermal power project at Talabira Jharsuguda District in Odisha NLC India is in the process of setting up a thermal power plant with a capacity of 2400 MW consisting of 3 units of 80OMW super critical technology This will be a pithead captive thermal […]
Ushanti Colour Chem will hold a meeting of the Board of Directors of the Company on 16 March 2022
The Board of Urja Global at its meeting held on 16 March 2022 has approved the appointment of Gaurav Aggarwal as Chief Executive Officer of the company The Board also approved to invest and subscribe to additional shares aggregating to Rs 2 crore in wholly owned subsidiary of the company Urja Batteries for enhancing production capacity The Board also approved setting up of assembling unit […]
Alankit will hold a meeting of the Board of Directors of the Company on 21 March 2022
Navoday Enterprises will hold a meeting of the Board of Directors of the Company on 21 March 2022
Sky Industries has approved the allotment of 61096 Equity Shares of face value of Rs 10 each of the Company to Options Grantee upon Exercise of Options vested under ESOP 2018
Mphasis has allotted 11910 equity shares under ESOP on 15 March 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
